Attached files

file filename
EX-31.1 - CERTIFICATION - ACRO BIOMEDICAL CO., LTD.acbm_ex311.htm
10-Q - FORM 10-Q - ACRO BIOMEDICAL CO., LTD.acbm_10q.htm

EXHIBIT 32.1

 

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of Acro Biomedical Co., Ltd. (the “Company”) on Form 10-Q for period ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof, I, Pao-Chi Chu, chief executive officer and chief financial officer of the Company, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

 

(1)

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

 

 

 

(2)

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

  

Date: May 19, 2020

 

 

By:

/s/ Pao-Chi Chu

 

Pao-Chi Chu

 

Chief Executive Officer and Chief Financial Officer

(Principal Executive Officer and Principal Financial Officer)